Teva Pharmaceutical Industries Aktie

16,20 EUR -0,05 EUR -0,31 %

16:12:38

FSE

17,14 USD +0,12 USD +0,68 %

16:13:50

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Div. Rendite0,00%

WKN883035

ISINUS8816242098

SymbolTEVA

Teva Pharmaceutical Industries Aktien News

Sortieren:Datum Meistgelesen

19.11.24GlobesDespite price cuts, Tesla loses its shine in Israel

08.11.24GlobeNewswireTeva to Present at the Jefferies London Healthcare Conference

08.11.24ZacksAre Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?

WerbungTeva Pharmaceutical Industries-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

07.11.24ZacksTEVA Stock Down 7% Despite Q3 Earnings & Sales Beat, Guidance Increase

06.11.24MotleyFoolTeva Pharmaceutical Industries (TEVA) Q3 2024 Earnings Call Transcript

06.11.24BenzingaGeneric Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast

06.11.24ZacksTeva Pharmaceutical Industries (TEVA) Reports Q3 Earnings: What Key Metrics Have to Say

06.11.24GlobesTeva reports seventh straight quarter of growth

04.11.24ZacksTeva Pharmaceutical Industries (TEVA) Upgraded to Strong Buy: What Does It Mean for the Stock?

01.11.24GlobeNewswireTeva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition

01.11.24GlobeNewswireTeva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanza

01.11.24ZacksCountdown to Teva Pharmaceutical Industries (TEVA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

31.10.24Financial TimesEU fines world’s largest generic drugmaker Teva for hindering competition

31.10.24GlobeNewswireTeva Statement on European Commission Decision; Company to Appeal

30.10.24GlobesTeva leapfrogs Check Point as Israel's most valuable company

25.10.24ZacksWall Street Analysts Predict a 25.1% Upside in Teva Pharmaceutical Industries (TEVA): Here's What You Should Know

23.10.24BenzingaA Closer Look at 4 Analyst Recommendations For Teva Pharmaceutical Indus

23.10.24ZacksShould Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?

23.10.24ZacksAre Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year?

22.10.24GlobeNewswireAlvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (us

18.10.24ZacksFOLD Stock Rises on Settling Galafold Patent Dispute With Teva

17.10.24BenzingaAmicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug

14.10.24GlobesTeva shareholder sues after $450m US settlement

13.10.24GlobesTeva settles further price-fixing lawsuits in the US

11.10.24BenzingaTeva Pays $450M To Resolve Alleged Kickback, Price-Fixing Schemes

10.10.24BenzingaHere's How Much $100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today

08.10.24GlobeNewswireTeva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA

07.10.24ZacksAre Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?

07.10.24ZacksIs Teva Pharmaceutical Industries (TEVA) Stock Outpacing Its Medical Peers This Year?

03.10.24GlobeNewswireTeva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate

01.10.24BenzingaTeva Launches Generic Version Of Sandostatin In The US

01.10.24GlobeNewswireTeva Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for injectable suspension), in the U.S.

30.09.24GlobeNewswireTeva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, 2024

30.09.24Benzinga$1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today

26.09.24GlobesTeva settles opioid suits in Israel

23.09.24GlobeNewswireTeva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia

21.09.24GlobeNewswireTeva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed

21.09.24GlobeNewswireNew Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000)

13.09.24ZacksTEVA Stock Rises 72.5% This Year: Time to Buy, Sell or Hold?

11.09.24GlobeNewswireTeva to Present at the Bank of America 2024 Global Healthcare Conference

Teva Pharmaceutical Industries News

Teva Pharmaceutical Industries News: auf dieser Seite finden Sie alle Teva Pharmaceutical Industries News und Nachrichten zur Teva Pharmaceutical Industries Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Teva Pharmaceutical Industries News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Teva Pharmaceutical Industries News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.